146 related articles for article (PubMed ID: 31217417)
1. Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer.
Dziobek K; Opławski M; Grabarek B; Zmarzły N; Januszyk P; Adwent I; Dąbruś D; Leśniak E; Kiełbasiński R; Kieszkowski P; Boroń D
Med Sci Monit; 2019 Jun; 25():4569-4574. PubMed ID: 31217417
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin Changes Expression of SEMA3B in Endometrial Cancer.
Peszek W; Kras P; Grabarek BO; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2020; 21(13):1368-1376. PubMed ID: 32410560
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial Cancer.
Dziobek K; Opławski M; Grabarek BO; Zmarzły N; Kieszkowski P; Januszyk P; Kiełbasiński K; Kiełbasiński R; Boroń D
Curr Pharm Biotechnol; 2020; 21(1):45-51. PubMed ID: 31544715
[TBL] [Abstract][Full Text] [Related]
4. Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.
Nguyen H; Ivanova VS; Kavandi L; Rodriguez GC; Maxwell GL; Syed V
Mol Cancer Res; 2011 Nov; 9(11):1479-92. PubMed ID: 21933904
[TBL] [Abstract][Full Text] [Related]
5. Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer.
Dziobek K; Opławski M; Grabarek BO; Zmarzły N; Tomala B; Halski T; Leśniak E; Januszyk K; Brus R; Kiełbasiński R; Boroń D
Curr Pharm Biotechnol; 2019; 20(11):955-963. PubMed ID: 31322068
[TBL] [Abstract][Full Text] [Related]
6. Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.
Joseph D; Ho SM; Syed V
Mol Cancer Ther; 2010 Feb; 9(2):499-509. PubMed ID: 20124444
[TBL] [Abstract][Full Text] [Related]
7. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
Shahi P; Wang CY; Chou J; Hagerling C; Gonzalez Velozo H; Ruderisch A; Yu Y; Lai MD; Werb Z
Oncogene; 2017 Oct; 36(40):5567-5575. PubMed ID: 28581515
[TBL] [Abstract][Full Text] [Related]
8. Analysis of SEMA3B methylation and expression patterns in gastric cancer tissue and cell lines.
Chen R; Zhuge X; Huang Z; Lu D; Ye X; Chen C; Yu J; Lu G
Oncol Rep; 2014 Mar; 31(3):1211-8. PubMed ID: 24402303
[TBL] [Abstract][Full Text] [Related]
9. SEMA3B improves the survival of patients with esophageal squamous cell carcinoma by upregulating p53 and p21.
Tang H; Wu Y; Liu M; Qin Y; Wang H; Wang L; Li S; Zhu H; He Z; Luo J; Wang H; Wang Q; Luo S
Oncol Rep; 2016 Aug; 36(2):900-8. PubMed ID: 27349960
[TBL] [Abstract][Full Text] [Related]
10. [Expression profile of genes associated with the histaminergic system estimated by oligonucleotide microarray analysis HG-U133A in women with endometrial adenocarcinoma].
Jeda A; Witek A; Janikowska G; Cwynar G; Janikowski T; Ciałon M; Orchel J; Mazurek U
Ginekol Pol; 2014 Mar; 85(3):172-9. PubMed ID: 24783427
[TBL] [Abstract][Full Text] [Related]
11. Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in Different Grades of Endometrial Cancer.
Oplawski M; Dziobek K; Zmarzły N; Grabarek B; Halski T; Januszyk P; Kuś-Kierach A; Adwent I; Dąbruś D; Kiełbasiński K; Boroń D
Curr Pharm Biotechnol; 2019; 20(12):1004-1010. PubMed ID: 31333122
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells.
Castro-Rivera E; Ran S; Brekken RA; Minna JD
Cancer Res; 2008 Oct; 68(20):8295-303. PubMed ID: 18922901
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases.
Varshavsky A; Kessler O; Abramovitch S; Kigel B; Zaffryar S; Akiri G; Neufeld G
Cancer Res; 2008 Sep; 68(17):6922-31. PubMed ID: 18757406
[TBL] [Abstract][Full Text] [Related]
15. Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B.
Koyama N; Zhang J; Huqun ; Miyazawa H; Tanaka T; Su X; Hagiwara K
Oncogene; 2008 Nov; 27(51):6581-9. PubMed ID: 18985860
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer.
Oplawski M; Dziobek K; Zmarzły N; Grabarek B; Tomala B; Leśniak E; Adwent I; Januszyk P; Dąbruś D; Boroń D
Curr Pharm Biotechnol; 2019; 20(6):483-488. PubMed ID: 30961491
[TBL] [Abstract][Full Text] [Related]
17. Placental SEMA3B expression is not altered in severe early onset preeclampsia.
Kaitu'u-Lino TJ; Hastie R; Cannon P; Binder NK; Lee S; Stock O; Hannan NJ; Tong S
Placenta; 2014 Dec; 35(12):1102-5. PubMed ID: 25454475
[TBL] [Abstract][Full Text] [Related]
18. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.
Nair PN; McArdle L; Cornell J; Cohn SL; Stallings RL
Cancer Genet Cytogenet; 2007 Apr; 174(2):100-10. PubMed ID: 17452250
[TBL] [Abstract][Full Text] [Related]
19. Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.
Loginov VI; Dmitriev AA; Senchenko VN; Pronina IV; Khodyrev DS; Kudryavtseva AV; Krasnov GS; Gerashchenko GV; Chashchina LI; Kazubskaya TP; Kondratieva TT; Lerman MI; Angeloni D; Braga EA; Kashuba VI
PLoS One; 2015; 10(5):e0123369. PubMed ID: 25961819
[TBL] [Abstract][Full Text] [Related]
20. Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B.
Cai G; Qiao S; Chen K
Biol Res; 2015 Jul; 48(1):37. PubMed ID: 26197878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
